Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Anatomic Stage I Breast Cancer AJCC v8 2Ovarian Neoplasms 1Genetic Predisposition to Disease 1Carcinoma, Ovarian Epithelial 1Alopecia 1

Interventions

Practice Guidelines as Topic 8Standard of Care 7Specimen Handling 7Early Intervention, Educational 5pertuzumab 3Trastuzumab 3Methods 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Educational Status 3trastuzumab biosimilar HLX02 2Taxes 2Paclitaxel 2PF-05280014 2Ontruzant 2Ogivri 2Minoxidil 2Letrozole 2High-Energy Shock Waves 2Docetaxel 2Biopsy 2Acupuncture Therapy 22C4 antibody 2regadenoson 1pembrolizumab 1palbociclib 1nilotinib 1lorcaserin 1fisetin 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Anatomic Stage I Breast Cancer AJCC v8 × Minoxidil × Clear all
NCT07594678 2026-05-19

Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients

Ohio State University Comprehensive Cancer Center

Phase 2 Not yet recruiting
50 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT05417308 2026-03-10

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
50 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡